Even assuming that up to 75% of people testing positive wouldn’t follow isolation guidance, the tests would greatly curtail infection, hospitalization, and death, argue investigators. The cost to the health care system would be worth it, investigators say.
Any national strategy to contain SARS-CoV-2, the virus fueling the COVID-19 pandemic, should include antigen-based at-home testing even if that testing is less than perfect and even if many who obtain the tests decide not to go through with them. Such at-home testing would greatly reduce hospitalizations, deaths, and the accompanying health care costs involved in treating individuals with COVID-19, according to a study in the Annals of Internal Medicine.1 That at-home testing is less than perfect has been a linchpin, with critics saying there would be too many false negatives and no guarantee people would take the tests. But the investigators—A. David Paltiel, PhD, of Yale School of Public Health; and Amy Zheng, BA; and Paul E. Sax, MD, both of Harvard Medical School—crunched the numbers and reached a different conclusion.
“High-frequency home testing for SARS-CoV-2 with an inexpensive, imperfect test could contribute to pandemic control at justifiable cost and warrants consideration as part of a national containment strategy,” the study states.
Using a traditional susceptible-exposed-infected-recovered compartmental epidemic modeling framework that they said represents individuals most likely to transmit the virus in the US population, the investigators computed what would happen if at-home testing were used, acknowledging that for a proportion of the population, the tests will show negative for people who are in fact positive for COVID-19. But even factoring that in, the results place at-home testing in a positive light, with results that investigators describe as “staggering in their magnitude.”
“Without a testing intervention, the model anticipates 11.6 million infections, 119,000 deaths, and $10.1 billion in costs [including] ($6.5 billion in inpatient care and $3.5 billion in lost productivity) over a 60-day horizon,” the study states. “Weekly availability of testing would avert 2.8 million infections and 15,700 deaths, increasing costs by $22.3 billion. Lower inpatient outlays ($5.9 billion) would partially offset additional testing expenditures ($12.5 billion) and workdays lost ($14.0 billion), yielding incremental cost-effectiveness ratios of $7890 per infection averted and $1.43 million per death averted.”
.Their conclusions apparently reached the ears of federal health care experts because the study is featured on the COVID-19 Science Update website maintained by the Centers for Disease Control and Prevention.2 Investigators tinkered a bit with the model methodology, splitting the infected compartment into 4 subgroups: asymptomatic, mild/moderate, severe, and critical.
“This permitted us to capture more fully the natural history, epidemiology, and resource use associated with progressive COVID-19,” the study states. “Second, we introduced a parallel set of states to distinguish between epidemiologically ‘susceptible or infectious’ individuals and persons no longer susceptible or infectious due to isolation or death. In ‘susceptible or infectious’ compartments, we assumed that individuals interact in ways that permit infectious contact and transmission of SARS-CoV-2; in ‘isolation’ compartments, no transmission was possible.”
Investigators tried to account for the unpredictability of individuals’ behavior, and purposely made what they described as highly pessimistic assumptions about how those who take the tests might react to the findings. They state that they “assumed that even among the minority who did perform the test, a large proportion (50% in the base case; 75% in the worst case) would elect to ignore a positive test finding and refuse to self-isolate. This means that in the worst case, only 6.25% (25% of 25%) of persons would be assumed to adhere to the recommended testing and isolation protocols. Finally, we assumed that even among that small proportion of persons who might elect to self-isolate, 20% each day would abandon isolation and return to the active population, against recommended guidance.”
Paltiel, Zheng, and Sax argue that they have included almost every possible reason why the at-home COVID-19 tests should not make a difference—and yet conclude that those tests would in fact make a huge difference. They urge readers to focus less on the numbers and more on their conclusion that a nationwide rollout of at-home tests would make sense. “Our bottom-line message is: Do not let the perfect be the enemy of the good; even a highly imperfect home-based testing program could confer enormous benefit.”
References:
Dear Helpdesk: Working in a Toxic Health Care Environment
March 28th 2024Dear Helpdesk is your steadfast companion, offering life coaching and workplace advice from 2 seasoned IPs for some of your most challenging real-life situations. Let us help you navigate the intersection between work and life, guiding you to navigate the dynamic world of infection prevention with confidence and grace. This article is on handling a toxic health care environment.
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Catching Up With Vangie Dennis, AORN 2022-2023 President at AORN 2024
March 26th 2024Infection Control Today (ICT) had the privilege of catching up with Vangie Dennis, MSN, RN, CNOR, CMLSO, at the Association of periOperative Registered Nurses' (AORN’s) International Surgical Conference & Expo 2024. As the former president of AORN and an esteemed figure in perioperative services, Vangie Dennis shared insights into her recent endeavors and the exciting new chapter she's embarked upon.
How To Optimize Your Time Management Strategies for the Busy Infection Preventionist
March 25th 2024Is your calendar resembling a chaotic masterpiece of overlapping tasks? Join the club of infection preventionists striving to balance responsibilities. Dive into proven strategies from a fellow infection preventionist to reclaim control of your time, streamline tasks, and boost productivity effectively. This is an IP Lifeline article.